Bicocca Open Archive

Logo unimib boa
CONTI, ELISA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.053
AS - Asia 5.486
EU - Europa 4.622
SA - Sud America 810
AF - Africa 150
Continente sconosciuto - Info sul continente non disponibili 15
OC - Oceania 14
Totale 21.150
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.789
SG - Singapore 1.872
CN - Cina 1.154
IT - Italia 963
VN - Vietnam 876
DE - Germania 804
RU - Federazione Russa 637
HK - Hong Kong 628
BR - Brasile 586
SE - Svezia 447
IE - Irlanda 364
GB - Regno Unito 338
UA - Ucraina 231
IN - India 223
FR - Francia 196
CA - Canada 186
AT - Austria 150
FI - Finlandia 141
TR - Turchia 104
BD - Bangladesh 102
AR - Argentina 84
KR - Corea 82
ID - Indonesia 71
DK - Danimarca 64
JP - Giappone 63
IQ - Iraq 58
PL - Polonia 51
ZA - Sudafrica 51
PK - Pakistan 50
MX - Messico 45
ES - Italia 44
NL - Olanda 44
BE - Belgio 38
PH - Filippine 35
EC - Ecuador 32
CO - Colombia 29
SA - Arabia Saudita 29
VE - Venezuela 27
EG - Egitto 26
UZ - Uzbekistan 24
MA - Marocco 20
CH - Svizzera 17
CL - Cile 17
CZ - Repubblica Ceca 17
AE - Emirati Arabi Uniti 13
EU - Europa 13
IR - Iran 13
LT - Lituania 13
MY - Malesia 12
AU - Australia 11
PE - Perù 11
DZ - Algeria 10
ET - Etiopia 9
HU - Ungheria 9
JO - Giordania 9
RO - Romania 9
TN - Tunisia 9
BO - Bolivia 8
KE - Kenya 8
PY - Paraguay 8
JM - Giamaica 7
AL - Albania 6
AZ - Azerbaigian 6
BH - Bahrain 6
PT - Portogallo 6
TH - Thailandia 6
UY - Uruguay 6
BG - Bulgaria 5
CR - Costa Rica 5
KZ - Kazakistan 5
NP - Nepal 5
OM - Oman 5
PA - Panama 5
PS - Palestinian Territory 5
SK - Slovacchia (Repubblica Slovacca) 5
TW - Taiwan 5
IL - Israele 4
LV - Lettonia 4
MN - Mongolia 4
NI - Nicaragua 4
SI - Slovenia 4
SN - Senegal 4
TT - Trinidad e Tobago 4
BY - Bielorussia 3
HN - Honduras 3
KG - Kirghizistan 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
SY - Repubblica araba siriana 3
GA - Gabon 2
GR - Grecia 2
GT - Guatemala 2
GY - Guiana 2
KH - Cambogia 2
LB - Libano 2
LY - Libia 2
MD - Moldavia 2
RS - Serbia 2
A1 - Anonimo 1
AM - Armenia 1
Totale 21.128
Salva come PNG Salva come JPEG
Città #
Ann Arbor 2.175
Singapore 1.146
Ashburn 843
San Jose 649
Hong Kong 600
Chandler 534
Woodbridge 523
Frankfurt am Main 458
Wilmington 377
Dublin 352
Houston 342
Milan 323
Fairfield 298
Ho Chi Minh City 289
Jacksonville 270
Dearborn 250
New York 236
Dallas 217
Hanoi 197
Los Angeles 190
Santa Clara 183
Beijing 168
Seattle 142
The Dalles 134
Vienna 133
Princeton 130
Chicago 121
Cambridge 109
Nanjing 98
Shanghai 84
Council Bluffs 77
Lauterbourg 72
Buffalo 69
São Paulo 69
Orem 65
Hefei 64
Seoul 62
Boardman 55
Helsinki 53
Jakarta 52
Lachine 51
Guangzhou 48
Moscow 47
Munich 46
Rome 46
Tokyo 46
London 41
Da Nang 40
Warsaw 40
Chennai 39
Brussels 37
Denver 36
Lawrence 36
Nanchang 33
Toronto 32
Haiphong 31
Atlanta 30
Dong Ket 30
Ottawa 30
Johannesburg 29
Brooklyn 27
Montreal 26
Nuremberg 26
Shenyang 26
Pune 25
Baghdad 24
Dhaka 23
Tianjin 23
Fremont 22
Stockholm 22
Altamura 21
Istanbul 21
Phoenix 21
San Diego 21
Biên Hòa 20
Lappeenranta 20
Changsha 19
Tashkent 19
Andover 18
Brasília 18
Falls Church 18
Manchester 18
Mumbai 18
Poplar 18
Rio de Janeiro 18
Amsterdam 17
Carate Brianza 17
Jinan 17
Zhengzhou 17
Belo Horizonte 16
Norwalk 16
Boston 15
Columbus 15
Hải Dương 15
Jiaxing 15
Quito 15
Ankara 14
Edmonton 14
Hebei 14
Lahore 14
Totale 13.740
Salva come PNG Salva come JPEG
Nome #
Increased tissue factor pathway inhibitor and homocysteine in Alzheimer's disease 555
QT interval and dispersion in drug-free anorexia nervosa adolescents: a case control study 490
QTc dispersion and interval changes in drug-free borderline personality disorder adolescents 483
Multifunctional liposomes interact with Abeta in human biological fluids: Therapeutic implications for Alzheimer's disease 455
Serum naturally occurring anti-TDP-43 auto-antibodies are increased in amyotrophic lateral sclerosis 440
Irisin and BDNF serum levels and behavioral disturbances in Alzheimer’s disease 429
THE TOXICITY OF AMYLOID-BETA OLIGOMERS AND TAU HYPERPHOSPHORYLATION ARE PREVENTED FROM LIPID-BASED NANOPARTICLES IN HUMAN PRIMARY FIBOBLASTS 424
Serum DBI and biomarkers of neuroinflammation in Alzheimer's disease and delirium 424
Decreased whole-blood global DNA methylation is related to serum hormones in anorexia nervosa adolescents. 422
Paradoxical Increase of plasma vitamin B12 and folates with disease severity in anorexia nervosa 415
Can Signaling Molecules in Fibroblasts Detect Prodromal Alzheimer's Disease? 414
Anorexia nervosa in adolescent girls and celiac disease serology 392
The one-carbon metabolism in anorexia nervosa of the restrictive type 375
Behavioural anomalies in neurodegenerative diseases: role of the immune response 367
Lipid-based nanoparticles counteract the oligomer abeta toxicity and tau phosphorylation in an ex-vivo biomolecular model of alzheimer disease 363
Author Correction: Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores (Nature Communications, (2021), 12, 1, (3417), 10.1038/s41467-021-22491-8) 360
Donepezil modulates the endogenous immune response: implications for Alzheimer's disease 360
Post-methionine load test: A more sensitive tool to reveal hyperhomocysteinemia in Alzheimer patients? 356
Stavudine Reduces NLRP3 Inflammasome Activation and Modulates Amyloid-β Autophagy 351
Riluzole Selective Antioxidant Effects in Cell Models Expressing Amyotrophic Lateral Sclerosis Endophenotypes 350
Diazepam binding inhibitor and dehydroepiandrosterone sulphate plasma levels in borderline personality disorder adolescents. 339
Peripheral sink effect as possible nanotherapeutic strategy for alzheimer’s disease: an ex vivo study 331
Beta-amyloid-induced peripheral chemotactic response: what role in Alzheimer’s disease? 330
TSPO Modulates Oligomeric Amyloid-β-Induced Monocyte Chemotaxis: Relevance for Neuroinflammation in Alzheimer's Disease 311
Valproate induces epigenetic modifications in lymphomonocytes from epileptic patients 311
Riluzole display glutamate-independent antioxidant properties: relevance for ALS 306
Clinical applicability of pCASL as a substitute for FDG-PET in the etiological diagnosis of MCI and SCD: CAPE study protocol 305
New insights into the genetic etiology of Alzheimer's disease and related dementias 303
Association of Variants in the SPTLC1 Gene With Juvenile Amyotrophic Lateral Sclerosis 299
Increased Soluble APPalpha, Abeta 1-42, and Anti-Abeta 1-42 Antibodies in Plasma From Down Syndrome Patients 294
Common variants in Alzheimer's disease and risk stratification by polygenic risk scores 293
Modulation of mapk phosphorylation in fibroblasts from alzheimer patients: erk involvment in glutamate transport and tau hyperphosporylation 293
Blood-based biomarkers of neuroinflammation in alzheimer’s disease: A central role for periphery? 285
Reduced fasting plasma levels of diazepam-binding inhibitor in adolescents with anorexia nervosa 284
Beta-amyloid plasma levels in adolescents with anorexia nervosa of the restrictive type 281
Anorexia nervosa of the restrictive type and celiac disease in adolescence 281
Pravastatin acute neuroprotective effects depend on blood brain barrier integrity in experimental cerebral ischemia 276
Cholinesterase inhibitor use is associated with increased plasma levels of anti-Aβ 1-42 antibodies in Alzheimer's disease patients 274
MAPK phosphorylation in fibroblasts from Alzheimer's disease patients: ERK involvement in EAAT1 expression and modulation with disease severity 271
Lipid-based nanoparticles as a potential tool to deplete abeta. Toward new therapeutic strategies for Alzheimer’s disease? 267
Multi-pathway blood biomarkers to target and monitor multidimensional prevention of cognitive and functional decline (nested in the IN-TeMPO study framed within the world-wide FINGERS network) 259
Plasma and cerebrospinal fluid cholesterol esterification is hampered in Alzheimer's disease 256
THE TOXIC EFFECT OF ABETA OLIGOMERS MAY BE REDUCED BY LIPID-BASED NANOPARTICLES IN HUMAN EX-VIVO MODELS 256
Longitudinal effects on plasma abeta levels of imatinib, a gamma-secretase activating protein inhibitor 256
Modulation of mapk phosphorylation in fibroblasts from alzheimer’s patients: the erk involvment in ad severity and eaat1 expression 255
Anti-Aβ autoantibodies in the CSF of a patient with CAA-related inflammation: a case report 252
Lipid-based nanoparticles as a potential tool to reduce abeta toxic effect in a human cellular model 251
Core blood biomarkers of Alzheimer's disease: A single-center real-world performance study 248
BDNF serum levels with respect to multidimensional assessment in amyotrophic lateral sclerosis 247
CLEARANCE OF BETA-AMYLOID OLIGOMERS BY PERIPHERAL MONOCYTES: FURTHER OBSERVATIONS REGARDING THE MODULATORY ROLE OF DONEPEZIL 244
the MonzALS collaborative network 242
Erk signalling modulates app metabolism, tau phosphorylation and eaat1 processing in fibroblasts from alzheimer’s patients 241
Binding of lipid-based nanoparticles to plasma abeta: relevance for new therapeutic strategies in Alzheimer’s disease 230
Anti-Abeta autoantibodies in cerebral amyloid angiopathy related inflammation: a role for pathogenesis? 229
Glibenclamide-Loaded Engineered Nanovectors (GNVs) Modulate Autophagy and NLRP3-Inflammasome Activation 225
Affective states and pathology in adolescents with borderline personality 222
Peripheral sink effect as possible nanotherapeutic strategy for alzheimer’s disease: an ex vivo study 222
Myocyte enhancer factor-2D expression in ALS lymphomonocytes 221
Modulation of MAPK- and PI3/AKT-Dependent Autophagy Signaling by Stavudine (D4T) in PBMC of Alzheimer’s Disease Patients 215
Behavioural Anomalies in Neurodegenerative Diseases: Role of the Immune Response 215
Role of donepezil in influencing endogenous immune response against abeta, an ex vivo and in vitro study 205
Predictors of response to acetylcholinesterase inhibitors in dementia: A systematic review 204
Plasma anti-amyloid-β autoantibodies in all Alzheimer disease types 203
Immune response against beta-amyloid is modulated by acetyl-cholinesterase inhibitors 190
Serum BDNF in amyotrophic lateral sclerosis decreases with disease severity 185
Novel therapeutic targets in neuropsychiatric disorders: the neuroepigenome 183
Acetyl-Cholinesterase Inhibitors Modulate The Autoimmune Response Against Beta-Amyloid 183
Mechanism-free repurposing of drugs for C9orf72-related ALS/FTD using large-scale genomic data 172
Valproate Treatment in an ALS Patient Carrying a c.194G>A Spastin Mutation and SMN2 Homozygous Deletion 170
Donepezil modulates the endogenous immune response in Alzheimer’s disease, an ex vivo and in vitro study 170
Whole-blood global DNA methylation and phenotypic variability in ALS 168
Further ex vivo evidence for a role of donepezil in the modulation of the immune response 162
Nilotinib or Dasatinib, but not Imatinib, might reduce Plasma Beta-Amyloid in Leukemia Patients : Implications gor Alzheimer’s Disease 160
Whole-blood global DNA methylation is increased in amyotrophic lateral sclerosis independently of age of onset 156
ALS genocopy due to co-existence of spastin mutation and SMN2 deletion? A 12 months open label trial with valproic acid 152
Multicomponent interventions and technologies to reduce the burden of frailty, functional, and cognitive decline: insights from the Age-It Research Program 134
Iatrogenic Cerebral Amyloid Angiopathy-Related Inflammation: A Multicenter Case Series 80
Cardiopulmonary and skeletal muscle strategies underlying exhaustive exercise in adults with glycogen storage disease type III 33
Cerebrospinal fluid CEFA composition is enriched in saturated fatty acids and it is altered in Alzheimer's Disease 21
Totale 21.876
Salva come PNG Salva come JPEG
Categoria #
all - tutte 61.999
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.999
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021268 0 0 0 0 0 0 0 0 0 0 102 166
2021/20221.111 139 145 124 110 71 67 55 50 48 61 85 156
2022/20231.924 192 525 218 207 131 281 36 108 129 25 44 28
2023/20241.311 62 60 71 66 161 323 233 46 59 23 18 189
2024/20253.070 171 277 212 113 238 166 207 141 304 477 263 501
2025/20268.003 1.058 474 665 850 1.123 461 1.387 372 686 833 94 0
Totale 21.876